MicroIslet Inc. Provides Safety and Efficacy Data Update

July 2, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SAN DIEGO--(BUSINESS WIRE)--MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report recent safety and efficacy data.

Twitter
LinkedIn
Facebook
Email
Print

Preclinical